Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes

Current Pharmaceutical Design

Volumn 19, Issue 11, 2013, Pages 2070-2083

  Leung, Mandy H M ^a   Harada, Takaaki ^a   Kee, Tak W ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Alzheimer's disease; Anti cancer; Anti oxidant; Copper; Curcumin; Drug delivery; Inflammation; Pro oxidant

Indexed keywords

CASEIN; COPPER ION; CURCUMIN; CYCLODEXTRIN; LIPOSOME; NANOPARTICLE; PLASMA PROTEIN; POLYMER; SURFACTANT;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING;

EID: 84875389167     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213805289237     Document Type: Article

References (136)

1. Sa G, Das T. Anti-cancer effects of curcumin: cycle of life and death. Cell Division 2008; 3(1): 1-14.
2. Ammon HPT, Wahl MA. Pharmacology of curcuma-longa. Planta Med 1991; 57(1): 1-7.
3. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Ann Indian Acad Neur 2008; 11(1): 13-19.
4. Roughley PJ, Whiting DA. Experiments in biosynthesis of curcumin. J Chem Soc Perkin Trans 1 1973(20): 2379-2388.
5. Vogel E, Pellertier S. J Pharm 1815; 2: 50-54.
6. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y. Nematocidal activity of turmeric - synergistic action of curcuminoids. Chem Pharm Bull 1993; 41(9): 1640-1643.
7. Kita T, Imai S, Sawada H, Kumagai H, Seto H. The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors. Biosci Biotechnol Biochem 2008; 72(7): 1789-1798.
8. Katsuyama Y, Kita T, Horinouchi S. Identification and characterization of multiple curcumin synthases from the herb Curcuma longa. FEBS Lett 2009; 583(17): 2799-2803.
9. Payton F, Sandusky P, Alworth WL. NMR study of the solution structure of curcumin. J Nat Prod 2007; 70(2): 143-146.
10. Chignell CF, Bilskj P, Reszka KJ, Motten AG, Sik RH, Dahl TA. Spectral and photochemical properties of curcumin. Photochem Photobiol 1994; 59(3): 295-302.
11. Wang ZF, Leung MHM, Kee TW, English DS. The role of charge in the surfactant-assisted stabilization of the natural product curcumin. Langmuir 2010; 26(8): 5520-5526.
12. Adhikary R, Carlson PJ, Kee TW, Petrich JW. Excited-state intramolecular hydrogen atom transfer of curcumin in surfactant micelles. J Phys Chem B 2010; 114(8): 2997-3004.
13. Adhikary R, Mukherjee P, Kee TW, Petrich JW. Excited-state intramolecular hydrogen atom transfer and solvation dynamics of the medicinal pigment curcumin. J Phys Chem B 2009; 113(15): 5255-5261.
14. Nardo L, Andreoni A, Masson M, Haukvik T, Tønnesen HH. Studies on curcumin and curcuminoids. XXXIX. Photophysical properties of bisdemethoxycurcumin. J Fluorescence 2011; 21(2): 627-635.
15. Priyadarsini KI. Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C 2009; 10(2): 81-95.
16. Bernabe-Pineda M, Ramirez-Silva MT, Romero-Romo M, Gonzadlez-Vergara E, Rojas-Hernandez A. Determination of acidity constants of curcumin in aqueous solution and apparent rate constant of its decomposition. Spectrochim Acta A 2004; 60(5): 1091-1097.
17. Shen L, Ji H-F. Theoretical study on physicochemical properties of curcumin. Spectrochim Acta A 2007; 67(3-4): 619-623.
18. Leung MHM, Colangelo H, Kee TW. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir 2008; 24(11): 5672-5675.
19. Kaminaga Y, Nagatsu A, Akiyama T, et al. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus. FEBS Lett 2003; 555(2): 311-316.
20. Letchford K, Liggins R, Burt H. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. J Pharm Sci 2008; 97(3): 1179-1190.
21. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4(6): 807-818.
22. Tønnesen HH, Karlsen J. Studies on curcumin and curcuminoids.6. kinetics of curcumin degradation in aqueous-solution. Z Lebensm Unters Forsch 1985; 180(5): 402-404.
23. Wang YJ, Pan MH, Cheng AL, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997; 15(12): 1867-1876.
24. Wennerstrom H, Lindman B. Micelles - physical-chemistry of surfactant association. Phys Rep 1979; 52(1): 1-86.
25. Nagarajan R, Ruckenstein E. Theory of surfactant self-assembly - a predictive molecular thermodynamic approach. Langmuir 1991; 7(12): 2934-2969.
26. Iwunze MO. Binding and distribution characteristics of curcumin solubilized in CTAB micelle. J Mol Liq 2004; 111(1-3): 161-165.
27. Tønnesen HH. Solubility, chemical and photochemical stability of curcumin in surfactant solutions - studies of curcumin and curcuminolds, XXVIII. Pharmazie 2002; 57(12): 820-824.
28. Bangham AD. Physical structure and behavior of lipids and lipid enzymes. Adv Lipid Res 1963; 1: 65-104.
29. Alving CR. Liposomes as carriers of antigens and adjuvants. J Immunol Methods 1991; 140(1): 1-13.
30. Lian T, Ho RJY. Trends and developments in liposome drug delivery systems. J Pharm Sci 2001; 90(6): 667-680.
31. Huwyler J, Wu DF, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 1996; 93(24): 14164-14169.
32. Tønnesen HH, Smistad G, Agren T, Karlsen J. Studies on curcumin and curcuminoids.23. effects of curcumin on liposomal lipidperoxidation. Int J Pharm 1993; 90(3): 221-668.
33. Chen C, Johnston TD, Jeon H, et al. An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 2009; 366(1-2): 133-139.
34. Barry J, Fritz M, Brender JR, Smith PES, Lee DK, Ramamoorthy A. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc 2009; 131(12): 4490-4498.
35. Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticleencapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy. J Nanobiotechnology 2007; 5(3): 18.
36. Mohanty C, Acharya S, Mohanty AK, Dilnawaz F, Sahoo SK. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. Nanomedicine 2010; 5(3): 433-449.
37. Scott MJ, Jones MN. The biodegradation of surfactants in the environment. BBA Biomemb 2000; 1508(1-2): 235-251.
38. Yam J, Booman KA, Broddle W, et al. Surfactants: a survey of short-term genotoxicity testing. Food Chem Toxicol 1984; 22(9): 761-769.
39. Sahu A, Kasoju N, Bora U. Fluorescence study of the curcumin&casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 2008; 9(10): 2905-2912.
40. Huppertz T, Fox PF, Kelly AL. Properties of casein micelles in high pressure-treated bovine milk. Food Chem 2004; 87(1): 103- 110.
41. Esmaili M, Ghaffari SM, Moosavi-Movahedi Z, et al. Beta caseinmicelle as a nano vehicle for solubility enhancement of curcumin; food industry application. LWT-Food Sci Technol 2011; 44(10): 2166-2172.
42. Yazdi SR, Corredig M. Heating of milk alters the binding of curcumin to casein micelles, a fluorescence spectroscopy study. Food Chem 2012; 132(3): 1143-1149.
43. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981; 33(1): 17-53.
44. Barik A, Priyadarsini KI, Mohan H. Photophysical studies on binding of curcumin to bovine serum albumin. Photochem Photobiol 2003; 77(6): 597-603.
45. Naik PN, Chimatadar SA, Nandibewoor ST. Study on the interaction between antibacterial drug and bovine serum albumin: a spectroscopic approach. Spectrochim Acta A 2009; 73(5): 841-845.
46. Leung MHM, Kee TW. Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir 2009; 25(10): 5773-5777.
47. FDA. alpha cyclodexrin. Food and Drug Administration; 2004
48. [updated 2012 Jun 30; cited 2012 Aug 3]; Available from: http: //www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation.cfm?rpt =grasListing&id=155.
49. FDA. beta cyclodexrin. Food and Drug Administration; 2001
50. [updated 2012 Jun 30; cited 2012 Aug 3]; Available from: http: //www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation.cfm?rpt =grasListing&id=74.
51. FDA. gamma cyclodexrin. Food and Drug Administration; 2000
52. updated 2012 Jun 30; cited 2012 Aug 3]; Available from: http: //www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation.cfm?rpt =grasListing&id=46
53. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem Rev 1998; 98(5): 1743-1753.
54. Lincoln SF, Pham D-T. Cyclodextrins: From nature to nanotechnology. Supramolecular Chemistry: From molecules to nanomaterials. John Wiley & Sons, Ltd; 2012.
55. Hoshino M, Imamura M, Ikehara K, Hama Y. Fluorescence enhancement of benzene-derivatives by forming inclusion complexes with beta-cyclodextrin in aqueous-solutions. J Phys Chem 1981; 85(13): 1820-1823.
56. Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007; 329(1-2): 1-11.
57. Loftsson T, Konradsdottir F, Masson M. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie 2006; 61(2): 83-89.
58. Rekharsky MV, Inoue Y. Complexation thermodynamics of cyclodextrins. Chem Rev 1998; 98(5): 1875-917.
59. Harada T, Pham D-T, Leung MHM, et al. Cooperative binding and stabilization of the medicinal pigment curcumin by diamide linked &-cyclodextrin dimers: a spectroscopic characterization. J Phys Chem B 2011; 115(5): 1268-1274.
60. Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002; 244(1-2): 127-135.
61. Baglole KN, Boland PG, Wagner BD. Fluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrins. J Photoch Photobio A 2005; 173(3): 230-237.
62. Singh R, Tønnesen HH, Vogensen SB, Loftsson T, Masson M. Studies of curcumin and curcuminoids. XXXVI. The stoichiometry and complexation constants of cyclodextrin complexes as determined by the phase-solubility method and UV-Vis titration. J Incl Phenom Macro 2010; 66(3-4): 335-348.
63. Pham DT, Clements P, Easton CJ, Papageorgiou J, Maya BL, Lincoln SF. Complexation of 6-(4 '-(toluidinyl)naphthalene-2- sulfonate by beta-cyclodextrin and linked beta-cyclodextrin dimers. New J Chem 2008; 32(4): 712-718.
64. Pham DT, Ngo HT, Lincoln SF, May BL, Easton CJ. Synthesis of C6(A)-to-C6(A) and C3(A)-to-C3(A) diamide linked gammacyclodextrin dimers. Tetrahedron 2010; 66(15): 2895-2898.
65. Hatcher H, Planalp R, Cho J, Tortia FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65(11): 1631-1652.
66. Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmermann BN. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 2005; 12(6-7): 445-452.
67. Gopinath D, Ahmed MR, Gomathi K, Chitra K, Sehgal PK, Jayakumar R. Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 2004; 25(10): 1911-1917.
68. Jagetia GC, Rajanikant GK. Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast Reconstr Surg 2005; 115(2): 515-28.
69. Jagetia GC, Rajanikant GK. Acceleration of wound repair by curcumin in the excision wound of mice exposed to different doses of fractionated gamma radiation. Int Wound J 2012; 9(1): 76-92.
70. Legeza V, Galenko-Yaroshevskii V, Zinov'ev E, et al. Effects of new wound dressings on healing of thermal burns of the skin in acute radiation disease. B Exp Biol Med 2004; 138(9): 311-315.
71. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23(1A): 363-398.
72. Suresh MV, Wagner MC, Rosania GR, et al. Pulmonary administration of water-soluble curcumin complex reduces ALI severity. Am J Respir Cell Mol Biol 2012.
73. Park JH, Kim HA, Park JH, Lee M. Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs. Biomaterials 2012; 33(27): 6542-6550.
74. Cartiera MS, Ferreira EC, Caputo C, Egan ME, Caplan MJ, Saltzman WM. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol Pharm 2010; 7(1): 86-93.
75. Egan ME, Pearson M, Weiner SA, et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004; 304(5670): 600-602.
76. Zeitlin P. Can curcumin cure cystic fibrosis? New Engl J Med 2004; 351(6): 606-608.
77. Lim GP, Chu T, Yang FS, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21(21): 8370-8377.
78. Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 2004; 75(6): 742-750.
79. Yang FS, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005; 280(7): 5892-5901.
80. Jiang T, Zhi X-L, Zhang Y-H, Pan L-F, Zhou P. Inhibitory effect of curcumin on the Al(III)-induced A&42 aggregation and neurotoxicity in vitro. BBA-Mol Basis Dis 2012; 1822(8): 1207-1215.
81. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an old-age disease with an age-old solution. Cancer Lett 2008; 267(1): 133-164.
82. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 1994; 54(22): 5841-5847.
83. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally-occurring plant phenolic compound. Cancer Res 1995; 55(2): 259-266.
84. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005; 41(13): 1955-1968.
85. Caruso F, Rossi M, Benson A, et al. Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene)Ru(curcuminato) chloro. J Med Chem 2011; 55(3): 1072-1081.
86. Lao CD, Ruffin MTT, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complem Altern M 2006; 6:10.
87. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997; 276(5309): 75-81.
88. Hardy J, Selkoe DJ. Medicine - the amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297(5580): 353-356.
89. Yanagisawa D, Shirai N, Amatsubo T, et al. Relationship between the tautomeric structures of curcumin derivatives and their A&- binding activities in the context of therapies for Alzheimer's disease. Biomaterials 2010; 31(14): 4179-4185.
90. Diaz-Cano SJ. General morphological and biological features of neoplasms: integration of molecular findings. Histopathology 2008; 53(1): 1-19.
91. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
92. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interf Sci 2010; 351(1): 19-29.
93. Yallapu MM, Jaggi M, Chauhan SC. &-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloid Surface B 2010; 79(1): 113-125.
94. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010; 31(25): 6597-6611.
95. Anitha A, Maya S, Deepa N, et al. Efficient water soluble Ocarboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym 2011; 83(2): 452-461.
96. Bush JA, Cheung KJJ, Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 2001; 271(2): 305-314.
97. Jaiswal AS, Marlow BP, Gupta N, Narayan S. Β-Catenin-mediated transactivation and cell - cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 2002; 21(55): 8414-8427.
98. Nagai S, Kurimoto M, Washiyama K, Hirashima Y, Kumanishi T, Endo S. Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines. Journal Neuro-Oncol 2005; 74(2): 105-111.
99. Jones PW, Taylor DM, Williams DR. Analysis and chemical speciation of copper and zinc in wound fluid. J Inorg Biochem 2000; 81(1-2): 1-10.
100. Sen CK, Khanna S, Venojarvi M, et al. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol-Heart Circul Physiol 2002; 282(5): H1821-H1827.
101. Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12(10): 1161-1208.
102. Kehrer JP. Free-radicals as mediators of tissue-injury and disease. Crit Rev Toxicol 1993; 23(1): 21-48.
103. Aizenman E, Stout AK, Harnett KA, Dineley KE, McLaughlin B, Reynolds IJ. Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 2000; 75(5): 1878-1888.
104. Kehrer JP. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 149(1): 43-50.
105. Miranda S, Opazo C, Larrondo LF, et al. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog Neurobiol 2000; 62(6): 633-648.
106. Yoshida D, Ikeda Y, Nakazawa S. Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors. J Neuro- Oncol 1993; 16(2): 109-115.
107. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998; 158(1): 47-52.
108. Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009; 35(1): 32-46.
109. Atwood CS, Moir RD, Huang XD, et al. Dramatic aggregation of Alzheimer a beta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 1998; 273(21): 12817-12826.
110. Brewer GJ, Yuzbasiyangurkan V. Wilson disease. Medicine 1992; 71(3): 139-164.
111. Cherny RA, Atwood CS, Xilinas ME, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001; 30(3): 665-676.
112. Sigurdsson EM, Brown DR, Alim MA, et al. Copper chelation delays the onset of prion disease. J Biol Chem 2003; 278(47): 46199-46202.
113. Barik A, Mishra B, Kunwar A, et al. Comparative study of copper(II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. Eur J Med Chem 2007; 42(4): 431-439.
114. Barik A, Mishra B, Shen L, et al. Evaluation of a new copper(II)- curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radical Bio Med 2005; 39(6): 811-822.
115. Baum L, Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimers Dis 2004; 6(4): 367-377.
116. Zhao X-Z, Jiang T, Wang L, Yang H, Zhang S, Zhou P. Interaction of curcumin with Zn(II) and Cu(II) ions based on experiment and theoretical calculation. J Mol Struct 2010; 984(1-3): 316-325.
117. Krishnankutty K, Venugopalan P. Metal chelates of curcuminoids. Syn React Inorg Met 1998; 28(8): 1313-25.
118. Dismukes JP, Jones LH, Bailar JC. Measurement of metal-ligand bond vibrations in acetylacetonate complexes. J Phys Chem 1961; 65(5): 792.
119. Addicoat MA, Metha GF, Kee TW. Density functional theory investigation of Cu(I)- and Cu(II)-curcumin complexes. J Comput Chem 2010; 32(3): 429-438.
120. Girolami GS, Jeffries PM, Dubois LH. Mechanistic studies of copper thin-film growth from Cu(I) and Cu(II) beta-diketonates. J Am Chem Soc 1993; 115(3): 1015-1024.
121. Leung MHM, Lincoln SF, Kee TW. Femtosecond transient absorption spectroscopy of copper(II)-curcumin complexes. Phys Chem Chem Phys 2012; 14(39): 13580-13587.
122. Dutta S, Murugkar A, Gandhe N, Padhye S. Enhanced antioxidant activities of metal conjugates of curcumin derivatives. Met-Based Drugs 2001; 8(4): 183-188.
123. Lou JR, Zhang X-X, Zheng J, Ding W-Q. Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kB and mTOR signaling pathways. Anticancer Res 2010; 30(9): 3249-3255.
124. Koiram PR, Veerapur VP, Kunwar A, et al. Effect of curcumin and curcumin copper complex (1:1) on radiation-induced changes of anti-oxidant enzymes levels in the livers of Swiss albino mice. J Radiat Res 2007; 48(3): 241-245.
125. Kunwar A, Narang H, Priyadarsini KI, Krishna M, Pandey R, Sainis KB. Delayed activation of PKC delta and NF kappa B and higher radioprotection in splenic lymphocytes by copper(II)- curcumin (1:1) complex as compared to curcumin. J Cell Biochem 2007; 102(5): 1214-1224.
126. Serpi C, Stanic Z, Girousi S. Electroanalytical study of the interaction between dsDNA and curcumin in the presence of copper(II). Talanta 2010; 81(4-5): 1731-1734.
127. Ahsan H, Hadi SM. Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Lett 1998; 124(1): 23-30.
128. Sakano K, Kawanishi S. Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Arch Biochem Biophys 2002; 405(2): 223-230.
129. Ahsan H, Parveen N, Khan NU, Hadi SM. Pro-oxidant, antioxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem-Biol Interact 1999; 121(2): 161-175.
130. Leung MHM, Mohan P, Pukala TL, Scanlon DB, Lincoln SF, Kee TW. Reduction of copper(II) to copper(I) in the copper-curcumin complex induces decomposition of curcumin. Aust J Chem 2012; 65(5): 490-495.
131. Kamau P, Jordan RB. Complex formation constants for the aqueous copper(I)-acetonitrile system by a simple general method. Inorg Chem 2001; 40(16): 3879-3883.
132. Kolthoff IM, Coetzee JF. Polarography in acetonitrile.2. metal ions which have significantly different polarographic properties in acetonitrile and in water - anodic waves - voltammetry at rotated platinum electrode. J Am Chem Soc 1957; 79(8): 1852-1858.
133. Nair J, Strand S, Frank N, et al. Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 2005; 26(7): 1307-1315.
134. Sahu SC, Washington MC. Effect of ascorbic-acid and curcumin on quercetin-induced nuclear-DNA damage, lipid-peroxidation and protein-degradation. Cancer Lett 1992; 63(3): 237-241.
135. Yoshino M, Haneda M, Naruse M, et al. Prooxidant activity of curcumin: copper-dependent formation of 8-hydroxy-2-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol In Vitro 2004; 18(6): 783-789.
136. Urbina-Cano P, Bobadilla-Morales L, Ramirez-Herrera MA, et al. DNA damage in mouse lymphocytes exposed to curcumin and copper. J Appl Genet 2006; 47(4): 377-382.